ArticleCureus2025

Refractory Hypophosphatemia Secondary to Tumor-Induced Osteomalacia: Diagnostic Challenges and Successful Management With Burosumab.

Amna Ramzan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.